[Mechanism of membranotropic effect of methylethyl(silatrane-1-yl methyl) sulfonium iodide].
Kuznetsov
I G
IG
Rasulov
M M
MM
Sorokin
M S
MS
Suslova
S K
SK
Voronkov
M G
MG
D000818:Animals; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology*; D019086:Bridged Bicyclo Compounds, Heterocyclic; D001952:Bridged-Ring Compounds / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects* / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D005456:Fluorescent Dyes; D066298:In Vitro Techniques; D008051:Lipid Bilayers; D015227:Lipid Peroxidation / Q000187:drug effects*; D008560:Membrane Fluidity / Q000187:drug effects; D008563:Membrane Lipids / Q000378:metabolism*; D008930:Mitochondria, Liver / Q000378:metabolism; D008968:Molecular Conformation; D051381:Rats; D012825:Silicon / Q000494:pharmacology*; D013452:Sulfonium Compounds
D001643:Bridged Bicyclo Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D001952:Bridged-Ring Compounds; D005456:Fluorescent Dyes; D008051:Lipid Bilayers; D008563:Membrane Lipids; D013452:Sulfonium Compounds; C058763:methylethyl(silatrane-1-ylmethyl)sulfonium; D000242:Cyclic AMP; D012825:Silicon
K voprosu o mekhanizme membranotropnogo deĭstviia metilétil(silatran-1-ilmetil) sul'foniĭ iodida.